Appendix I: Working Group Members
L. Bonnicksen, Ph.D., is professor and former chair of
the Department of Political Science at Northern Illinois University, where she
teaches courses in biomedical and biotechnology policy. She publishes on issues related to
reproductive and genetic technologies.
Dr. Bonnicksen is a member of the Ethics Committee of the American
Society for Reproductive Medicine.
M. Byers, Ph.D., is executive director of the
Committee on Science and Human Values, National Conference of Catholic
Bishops. The Committee conducts
dialogues with scientists on a wide variety of issues, bringing Catholic
theology and moral thought into contact with advances in modern science and
Campbell, Ph.D., is associate professor of Philosophy
at Oregon State University, and the director of the Program for Ethics,
Science, and the Environment. He has
written extensively on biomedical ethics, including papers for the National
Bioethics Advisory Commission on human cloning and on research on human
tissue. Dr. Campbell had previously
been a research associate at The Hastings Center and was the editor of The Hastings Center Report.
S. Davis, J.D., Ph.D. (Religious Studies), is
associate professor at Cleveland-Marshall College of Law. She writes frequently on issues of genetics
and reproduction. In 1998-1999, she was
a Visiting Scholar at the National Human Genome Research Institute (NIH). She is legal consultant to the Committee on
Bioethics of the American Academy of Pediatrics.
Rian Evans, M.Div, Ph.D., is Charlotte W. Newcombe
professor of practical theology, and academic coordinator of field education at
Princeton Theological Seminary. She
specializes in bioethics and health ministries, and is especially concerned
with recapturing the historic health and healing ministry of the early
church. Her books Redeeming Marketplace Medicine and The Healing Church address a theologically
based health care reform model, a subject she was involved in while serving on
the Clinton Health Care Task Force.
Since the 1980s she has done research and writing on genetics,
especially concerning reproductive technologies. Dr. Evans is an ordained minister in the Presbyterian Church
T. FitzGerald, S.J., Ph.D., is a Research Associate in
the Department of Medicine and the Medical Humanities Program at the Loyola
University Medical Center in Chicago.
His two principal research foci are the investigation of abnormal gene
regulation in cancer and ethical issues in medical genetics. He is currently completing a second
doctorate in bioethics. Father
FitzGerald is a Roman Catholic priest and a member of the Society of Jesus
Fost, M.D., M.P.H., is Professor of Pediatrics and
Director of the Program in Medical Ethics at the University of Wisconsin School
of Medicine. There, he is chair of the
Health Sciences Human Subjects Committee, the Institutional Review Board
responsible for the stem cell research conducted by James Thomson. He also chairs the Universitys Bioethics
Advisory Committee. Dr. Fost is past
chair of the American Academy of Pediatrics Committee on Bioethics and was a
member of the Clinton Health Care Task Force.
Goldman, Ph.D., is the Stephen Walter Ranson Professor
and Chairman of the Department of Cell and Molecular Biology, Northwestern
University School of Medicine. His
laboratorys research focuses on the structure and function of intermediate
filaments of cellular cytoskeletal systems that shape cells and allow them to
carry out diverse physiological functions.
Dr. Goldman is a Fellow of the American Association for the Advancement
of Science and a member of its Board of Directors. He has taught at the Woods Hole Marine Biological Laboratory and
is Co-Director of the Science Writing Fellowship Program there.
A. Goldstein, Ph.D., M.D., currently serves as the
Vice President for Research of the Juvenile Diabetes Foundation (JDF), and is
responsible for planning and administration of their research funding programs
aimed at finding a cure for Type 1 Diabetes and its complications (in FY2000,
JDF will fund more than $75 million in grants and training awards). Prior to joining JDF in 1997, he was
Director, Division of Allergy, Immunology and Transplantation at the National
Institute of Allergy and Infectious Diseases (NIH).
Gottlieb, Ph.D., is Professor of Neurobiology at
Washington University School of Medicine in St. Louis, Missouri. About 5 years ago his research interests in
brain development lead him to study ES cells as a potential model system. Together with colleagues at Washington
University, he demonstrated that ES cells could be efficiently differentiated into
neurons and glia. He is currently utilizing
this system to explore mechanisms of neural differentiation and is part of a
team investigating their application to spinal cord injury research.
M. Green, Ph.D., is the Eunice and Julian Cohen
Professor for the Study of Ethics and Human Values in the Religion Department,
Dartmouth College, and is the Director of Dartmouths Ethics Institute. In 1994, he was a member of the National
Institutes of Health Human Embryo Research Panel. In 1996-97, he served, half time, as the founding director of the
Office of Genome Ethics at NIHs National Human Genome Research Institute. Dr. Green has been president of the Society
of Christian Ethics and is Secretary of the American Academy of Religion, the
largest association of scholars of religion in the United States.
R. Marshak, Ph.D., is Senior Vice President and Chief
Scientific Officer of Osiris Therapeutics Inc., a biotechnology company in
Baltimore, Maryland, specializing in adult stem cell products for Regenerative
Medicine. He holds an appointment as
Adjunct Associate Professor of Oncology and of Molecular Biology and Genetics
at The Johns Hopkins University School of Medicine. Dr. Marshak currently serves on the Editorial Board of The Journal of Biological Chemistry and
the Scientific Advisory Board of the Dystonia Medical Research Foundation.
Ben Mitchell, Ph.D., is consultant on biomedical and
life issues for the Southern Baptist Ethics and Religions Liberty Commission,
the moral concerns, public policy, and religious liberty agency of the Southern
Baptist Convention. He teaches
bioethics and contemporary culture at Trinity International University in
Deerfield, Illinois. He has written
widely in the area of bioethics and public policy, served on the AAAS working
group on gene patenting, and is editor of the American
Journal of Ethics & Medicine.
Perry is Executive Director of the not-for-profit
Alliance for Aging Research in Washington, D.C. His organization promotes a broad agenda of medical and
behavioral research for improving the health and independence of older
Americans. He also chairs the Patients
Coalition for Urgent Research (Patients CURe), an umbrella group of more than
30 national patient advocacy groups that works to project the concerns of
patients and their families into public deliberations over stem cell research.
Wachbroit, Ph.D., is a Research Scholar at the School
of Public Affairs Institute for Philosophy and Public Policy at the University
of Maryland. He is also Adjunct
Associate Professor of Obstetrics and Gynecology in the Universitys School of
Medicine as well as a Senior Research Fellow at the Kennedy Institute of Ethics
at Georgetown University. From 1987 to
1991, he held a joint appointment with the Institute for Philosophy and Public Policy
and the Maryland Biotechnology Institutes Center for Public Issues in
R. Woollett, M.A., D.Phil., is Associate Vice
President for Biologics and Biotechnology at the Pharmaceutical Research and
Manufacturers of America (PhRMA). In
addition to overseeing all activities concerning biologics and biotechnology,
her responsibilities include staffing the PhRMA Biomedical Research Key Issue
Team (a high level industry forum for the discussion of the promise, ethics,
and impact of new DNA technologies in
health care, among other topics). Dr.
Woollett also has responsibility for representing the pharmaceutical industry
internationally, for example, by contributing industry ideas to the development
of the proposed Compliance Protocol to be added to the Biological Weapons
Zoloth, Ph.D., is Associate Professor of Social Ethics
and Jewish Philosophy and Chair of the Jewish Studies Program in the College of
Humanities at San Francisco State University.
She is on the national board of the American Society for Bioethics and
Humanities and is a member of the advisory committee for the Program of
Dialogue on Science, Ethics, and Religion (AAAS). Dr. Zoloth is also a member of the Geron Ethics Advisory
Board. Her most recent book is Health Care and the Ethics of Encounter: A Jewish
Discussion of Social Justice, and she is co-editor with Dena S.
Davis of Notes from a Narrow Ridge: Religion
link | Printer-friendly | Feedback
| Contributed by: AAAS DoSER and the Institute for